Search

Your search keyword '"Aykut Cilli"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Aykut Cilli" Remove constraint Author: "Aykut Cilli"
91 results on '"Aykut Cilli"'

Search Results

1. Clinical features of patients with asthma, bronchiectasis, and combination of both conditions

2. Self-reported continuous positive airway pressure device compliance of patients with obstructive sleep apnoea syndrome

3. Effects of the COVID-19 pandemic on the follow-up and treatment of patients with idiopathic pulmonary fibrosis: a cross-sectional, multicentre phone call survey

4. Comparison of positional and rapid eye movement-dependent sleep apnea syndromes

5. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation

6. WAO International Scientific Conference (WISC 2016) Abstracts

7. Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions

8. Alterations in plasma miR-21, miR-590, miR-192 and miR-215 in idiopathic pulmonary fibrosis and their clinical importance

9. Pulmonary Abscess as a Complication of SARS-CoV-2 Pneumonia

10. Clinical Course of Coronavirus disease 2019 C-19 in Patients with Bronchiectasis

11. Clinical features of patients with asthma, bronchiectasis, and combination of both conditions

12. Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study

13. The Role of Pneumococcal Pneumonia among Community-Acquired Pneumonia in Adult Turkish Population: TurkCAP Study

14. Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis

15. Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study

16. Bronchiectasis in Türkiye: Data from a Multicenter Registry (Turkish Adult Bronchiectasis Database)

17. Effects of coronavirus disease 2019 (COVID-19) pandemic on the follow-up and treatment of patients with idiopathic pulmonary fibrosis: a cross-sectional multicenter study phone call survey

18. Effects of the COVID-19 pandemic on the follow-up and treatment of patients with idiopathic pulmonary fibrosis: a cross-sectional, multicentre phone call survey

19. Morbidity and mortality of surgical lung biopsy in the diagnosis of usual interstitial pneumonia

20. Evaluation of efficacy and safety of pirfenidone 200 mg tablets in patients with idiopathic pulmonary fibrosis in a real-life setting

22. Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial

23. Comparison of positional and rapid eye movement-dependent sleep apnea syndromes

24. Omalizumab Treatment in Patients with Severe Allergic Asthma

25. The effect of inhaled corticosteroids in the outcomes of community-acquired pneumonia: ICCAP study (TURKCAP Database)

26. Factors Affecting Cost of Patients with Severe Community-Acquired Pneumonia in Intensive Care Unit

27. Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients

28. Efficacy and safety profile of roflumilast in a real-world experience

30. Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma

31. Acute cardiac events in severe community-acquired pneumonia: A multicenter study

32. Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study

33. Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia

34. Antibiotic treatment outcomes in community-acquired pneumonia

35. Prognosis of hospitalized patients with community-acquired pneumonia

36. An Asymptomatic Case of Hamartoma Located in the Trachea

37. Intrahospital cardiovascular complications in severe community-acquired pneumonia

39. Right Aortic Arch Anomaly Masqurading As Bronchial Asthma

40. The yield of tigecycline in the treatment of community-acquired pneumonia

41. Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

42. The pilgrimage and the burden of pneumococcal disease in adults

43. Real life profile of asthma and chronic obstructive pulmonary disease patients in Turkey

44. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation

45. Factors affecting treatment success in community-acquired pneumonia

46. Effectiveness evaluation of anti-IgE treatment at 3rdyear: Real life Turkey data

47. Comparison of positional and REM-related obstructive sleep apnea

48. Omalizumab treatment in asthma-COPD overlap syndrome

50. A pharmacovigilance study in chest diseases outpatient clinic

Catalog

Books, media, physical & digital resources